Gilead Sciences reported $27.91B in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0M 0.17M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
ALKERMES ALKS:US 293.44M 633K
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amgen AMGN:US $ 33291M 4833M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Biogen BIIB:US $ 6272.3M 996.9M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Coherus Biosciences CHRS:US $ 281.9M 5.18M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Glaxosmithkline GSK:US $ 20736M 294M
GlaxoSmithKline GSK:LN 20736M 294M
Moderna Inc MRNA:US $ 238M 90M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NOVN:VX SF 24715M 1776M
Ptc Therapeutics PTCT:US $ 972.21M 143.17M
Puma Biotechnology PBYI:US $ 96.8M 28.1M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
YTE INCY:US $ 31.38M 0.46M